Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
On January 17, 2025, the staff at the Federal Trade Commission (FTC) released their first results from the FTC’s Surveillance Pricing market ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
A staff report released Friday by the FTC suggested partnerships between OpenAI and Microsoft, and Amazon and Anthropic, ...
In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...
The U.S. Federal Trade Commission (FTC) on Friday found that the partnerships between Microsoft ( NASDAQ: MSFT ), Amazon ( ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...
TechCrunch on MSN7d
FTC says partnerships like Microsoft-OpenAI raise antitrust concernsThe Federal Trade Commission (FTC) said in a staff report issued Friday that there are potential competitive issues in ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
Surmodics (NASDAQ:SRDX) dropped 5.8% after a report about the Federal Trade Commission's review of its planned sale to private equity firm GTCR. The staff of the FTC has some concerns about the $627 ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback